Opening Remarks from the Co-Chairs

November 29, 2023 8:30am

Tashica Williams Amirgholizadeh, Ph.D.
Senior Associate General Counsel, IP,
IP Alliance and Due Diligence (IPADD), Team Lead

Gilead Sciences, Inc.

Hilary Libka
Chief IP Counsel, Associate General Counsel
Memorial Sloan-Kettering Cancer Center

Michael Penn
Vice President, IP
BlueRock Therapeutics